StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Freenome total assets

Total assets on the balance sheet at the end of each period.

Freenome's total assets was $733.53M at Sep 30, 2026. For fiscal 2025 it was $507.05M, up 464.0% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$507.05M+464.0%
FY2024Dec 31, 2024$89.90M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$733.53M+695.6%
Q2 FY2026Jun 30, 2026$85.83M-6.1%
Q1 FY2026Mar 31, 2026$93.33M+3.0%
Q4 FY2025Dec 31, 2025$507.05M+464.0%
Q3 FY2025Sep 30, 2025$92.20M+3.6%
Q2 FY2025Jun 30, 2025$91.40M+4.0%
Q1 FY2025Mar 31, 2025$90.63M–
Q4 FY2024Dec 31, 2024$89.90M–
Q3 FY2024Sep 30, 2024$89.01M–
Q2 FY2024Jun 30, 2024$87.89M–

More Freenome figures

See a number that looks wrong?